We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
This item is currently unavailable
The 2021-2026 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)
Price data last checked 27 day(s) ago - will refresh soon
One email. No newsletter. No nudges.
Gone for 204 days. Could come back at any time — we're watching for you.
Out of stock 204 days · last price £795 · longest previous gap was 1 days
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 704 days • 704 data points (No recent data available)
Price Distribution
Price distribution over 704 days • 1 price levels
Price Analysis
Most common price: £795 (704 days, 100.0%)
Price range: £795 - £795
Price levels: 1 different prices over 704 days
Product Specifications
- Format
- paperback
- ASIN
- B082JNQFH4
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 13 February 2020
- Listed Since
- 13 December 2019
Similar Products You Might Like
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Japan
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China
The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Africa
The 2016 Report on Therapeutic Monoclonal Antibody (Mab)-Based Products: World Market Segmentation by City
The 2025-2030 World Outlook for Breast Cancer Screenings
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in North America & the Caribbean
The 2023 Report on Therapeutic Monoclonal Antibody (Mab)-Based Products: World Market Segmentation by City
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
The 2026-2031 World Outlook for Breast Cancer Liquid Biopsies
The 2023-2028 Outlook for Breast Cancer Screenings in the United States
The 2021-2026 World Outlook for Breast Biopsies
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
The 2023-2028 Outlook for Monoclonal Antibodies Protein Therapeutics in Japan
The 2021-2026 World Outlook for Vacuum-Assisted Breast Biopsy (VABB) Devices
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India
